BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34542087)

  • 21. What Are the Clinical Factors That Are Predictive of Persistent Pessary Use at 12 Months?
    Chan MC; Hyakutake M; Yaskina M; Schulz JA
    J Obstet Gynaecol Can; 2019 Sep; 41(9):1276-1281. PubMed ID: 30712905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial.
    Cheung RY; Lee JH; Lee LL; Chung TK; Chan SS
    Obstet Gynecol; 2016 Jul; 128(1):73-80. PubMed ID: 27275798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neglected doughnut pessary in the uterine cavity.
    Asumpinwong C; Leerasiri P; Hengrasmee P
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 30988106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in the symptoms and quality of life of women with symptomatic pelvic organ prolapse fitted with a ring with support pessary.
    Mao M; Ai F; Zhang Y; Kang J; Liang S; Xu T; Zhu L
    Maturitas; 2018 Nov; 117():51-56. PubMed ID: 30314561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Arterial Vaginal Bleed Resulting from Short-Term Pessary Use: A Case Report.
    Rieben K; Epp A
    J Obstet Gynaecol Can; 2021 Apr; 43(4):503-505. PubMed ID: 33153940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse.
    Mao M; Ai F; Kang J; Zhang Y; Liang S; Zhou Y; Zhu L
    Menopause; 2019 Feb; 26(2):145-151. PubMed ID: 30130292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An estriol-eluting pessary to treat pelvic organ prolapse.
    Long J; Zidan G; Seyfoddin A; Tong S; Brownfoot FC; Chowdary P
    Sci Rep; 2022 Nov; 12(1):20021. PubMed ID: 36414726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal pessaries for treatment of pelvic organ prolapse in elderly women.
    Griebling TL
    Curr Opin Urol; 2016 Mar; 26(2):201-6. PubMed ID: 26765048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Complications related to pessary use in the treatment of female pelvic organ prolapse].
    Mooij R; Potijk TM; Schrickx JA
    Ned Tijdschr Geneeskd; 2021 Jul; 165():. PubMed ID: 34346635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staged repair of concomitant rectovaginal fistula and pelvic organ prolapse after removal of a neglected pessary.
    Mathews S; Laks S; LaFollette C; Montoya TI; Maldonado PA
    Proc (Bayl Univ Med Cent); 2020 Jul; 33(4):686-688. PubMed ID: 33100572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Female pelvic organ prolapse using pessaries: systematic review.
    de Albuquerque Coelho SC; de Castro EB; Juliato CR
    Int Urogynecol J; 2016 Dec; 27(12):1797-1803. PubMed ID: 26992725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal Pessaries for Pelvic Organ Prolapse and Their Impact on Sexual Function.
    Rantell A
    Sex Med Rev; 2019 Oct; 7(4):597-603. PubMed ID: 31378507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pessary treatment for pelvic organ prolapse and health-related quality of life: a review.
    Lamers BH; Broekman BM; Milani AL
    Int Urogynecol J; 2011 Jun; 22(6):637-44. PubMed ID: 21472447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is hysterectomy or prior reconstructive surgery associated with unsuccessful initial trial of pessary fitting in women with symptomatic pelvic organ prolapse?
    Nemeth Z; Farkas N; Farkas B
    Int Urogynecol J; 2017 May; 28(5):757-761. PubMed ID: 27796427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with pessary fitting in women with symptomatic pelvic organ prolapse: A large prospective cohort study.
    Ma C; Xu T; Kang J; Zhang Y; Ma Y; Liang S; Zhu L
    Neurourol Urodyn; 2020 Nov; 39(8):2238-2245. PubMed ID: 32936968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaginal Pessary for Pelvic Organ Prolapse: A French Multidisciplinary Survey.
    Pizzoferrato AC; Nyangoh-Timoh K; Martin-Lasnel M; Fauvet R; de Tayrac R; Villot A
    J Womens Health (Larchmt); 2022 Jun; 31(6):870-877. PubMed ID: 34569823
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors associated with long-term pessary use in women with symptomatic pelvic organ prolapse.
    Mao M; Xu T; Kang J; Zhang Y; Ai F; Zhou Y; Zhu L
    Climacteric; 2019 Oct; 22(5):478-482. PubMed ID: 30897024
    [No Abstract]   [Full Text] [Related]  

  • 38. Unusual Perils of Pelvic Organ Prolapse.
    Liu BJ; Lee PE
    J Obstet Gynaecol Can; 2017 Nov; 39(11):1038-1041. PubMed ID: 28733058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A predictive model of choosing pessary type for women with symptomatic pelvic organ prolapse.
    Xu H; Wu W; Wang X; Xia Z
    Menopause; 2021 Oct; 28(11):1279-1286. PubMed ID: 34636355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaginal ring pessary use for pelvic organ prolapse: continuation rates and predictors of continued use.
    Manonai J; Sarit-Apirak S; Udomsubpayakul U
    Menopause; 2018 Dec; 26(6):665-669. PubMed ID: 30562318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.